atients should be periodically reassessed to determine the continued need for maintenance treatment and the appropriate dose for such treatment [see Clinical Studies (14.2)]. *********************************************************** The information contained in this communication is confidential, may be attor

atients should be periodically reassessed to determine the continued need for maintenance treatment and the appropriate dose for such treatment [see Clinical Studies (14.2)]. ■eeeeeeeeeeeeeeeeerreeeeeeee■*rrrr*********rr******eeeeeeee The information contained in this communication is confidential, may be attor